文献速递瓣膜外科

植入主动脉瓣或二尖瓣位置的生物瓣膜耐久性:一项全国性队列研究

Durability of Biological Valves Implanted in Aortic or Mitral Positions: A Nationwide Cohort Study.
PubMed 文献 · Ann Thorac Surg · 2023-06-24

该研究基于台湾全民健康保险研究数据库,比较2001至2017年间因主动脉瓣或二尖瓣置换植入生物瓣膜患者的长期耐久性,以再次手术为主要结局。倾向评分匹配后主动脉瓣与二尖瓣置换队列各2259例,二尖瓣队列再次手术率3.5%高于主动脉瓣队列2.6%(HR 1.41;95%CI 1.01-1.98),全因死亡风险亦更高(36.5% vs 32.6%;HR 1.21;95%CI 1.10-1.34)。

要点

  • 二尖瓣位置生物瓣再次手术率3.5%,高于主动脉瓣位置的2.6%(HR 1.41;95%CI 1.01-1.98)。
  • 二尖瓣位置全因死亡36.5%,高于主动脉瓣位置的32.6%(HR 1.21;95%CI 1.10-1.34)。
  • 双瓣置换使用同类型生物瓣者,主动脉位置瓣膜需再次植入的可能性明显更低。

核心结论

  • 主动脉位置植入生物瓣膜在耐久性、长期死亡率和围手术期并发症方面结局更优。
  • 开发新干预措施并提高瓣膜耐久性可扩大生物瓣膜在瓣膜置换中的应用。

研究设计与样本

  • 利用台湾全民健康保险研究数据库开展的全国性队列研究,纳入2001至2017年间住院并接受生物瓣膜置换的患者。
  • 比较二尖瓣与主动脉瓣位置生物瓣膜的耐久性,主要结局为再次手术。
  • 采用受试者间和受试者内两种设计,受试者间设计构建1:1倾向评分匹配队列。
  • 共识别10308例患者,其中5462例接受主动脉瓣置换,3901例接受二尖瓣置换,945例接受双瓣置换。
  • 匹配后主动脉瓣置换和二尖瓣置换队列各2259例。

主要发现

  • 平均随访4.2年(范围1天至17.9年)。
  • 二尖瓣置换队列再次手术率3.5%,高于主动脉瓣置换队列的2.6%(HR 1.41;95%CI 1.01-1.98)。
  • 二尖瓣置换队列全因死亡36.5%,高于主动脉瓣置换队列的32.6%(HR 1.21;95%CI 1.10-1.34)。
  • 接受双瓣置换且使用同一类型人工瓣膜的患者中,植入主动脉位置的瓣膜需再次植入的可能性明显更低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biologic prostheses are being increasingly used for aortic and mitral valve replacement (AVR and MVR). This study evaluated the long-term durability of bioprosthetic valves in the mitral and aortic positions, as no well-designed population-based studies have addressed this issue before. METHODS: Using Taiwan's National Health Insurance Research Database, we compared biologic valve durability in the mitral and aortic positions in patients hospitalized between 2001 and 2017, with reoperation as the primary outcome. Both between-subject and within-subject designs were used, and the propensity score matching cohort (1:1 ratio) was created for the former. RESULTS: We identified a total of 10,308 patients, 5462 of whom received AVR, 3901 received MVR, and 945 received double valve replacement. Both AVR and MVR cohorts had 2259 patients after matching. During a mean follow-up of 4.2 years (range, 1 day to 17.9 years), the reoperation rate in the MVR cohort (3.5%) was higher than that in the AVR cohort (2.6%) (hazard ratio 1.41; 95% CI, 1.01-1.98). A higher risk of all-cause death was observed in the MVR cohort (36.5%) than in the AVR cohort (32.6%) (hazard ratio 1.21; 95% CI, 1.10-1.34). Among patients receiving double valve replacement with the same prosthesis type, valves implanted in the aortic position were considerably less likely to require reimplantation. CONCLUSIONS: Bioprosthetic valve placement in the aortic position is associated with superior outcomes in terms of durability, long-term mortality, and perioperative morbidity. Developing novel interventions and enhancing valve durability would expand bioprosthesis use for valve replacement.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Chen CY, Lin CP, Hung KC, et al. Durability of Biological Valves Implanted in Aortic or Mitral Positions: A Nationwide Cohort Study. Ann Thorac Surg. 2023. PMID: 37356516. doi:10.1016/j.athoracsur.2023.05.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。